Antonella De Matteis at the Galileo festival

Pioneering the Research on Lowe Syndrome
May 08, 2024
Antonella De Matteis at the Galileo festival

Antonella De Matteis at the Galileo Testival 2024

Pioneering the Research on Lowe Syndrome: Dr. Antonella De Matteis at the Galileo Festival

At the Galileo Festival, an annual celebration of scientific innovation and exploration, Dr. Antonella De Matteis introduced her groundbreaking work on Lowe Syndrome, a rare genetic disorder. This event marked an important occasion not only for the scientific community but also for patients suffering from rare diseases around the world.

Understanding Lowe Syndrome

Lowe Syndrome, also known as Oculocerebrorenal Syndrome, is a rare genetic condition characterized primarily by major problems in the eyes, brain, and kidneys. It occurs in approximately one in 500,000 newborns and almost exclusively affects males. The disease manifests in various forms such as cataracts, muscle hypotonia, intellectual disabilities, and renal complications. Due to its rarity and complexity, Lowe Syndrome requires more visibility and research to understand and manage its wide-ranging impacts effectively.

Dr. Antonella De Matteis' Role

Dr. Antonella De Matteis has dedicated a significant portion of her career to researching Lowe Syndrome. Initially trained as a medical doctor, Dr. De Matteis pivoted to research, driven by a desire to understand the molecular underpinnings of rare diseases like Lowe Syndrome. Her work is pivotal in elucidating how disruptions in cellular mechanisms contribute to the disease's symptoms.

Recognizing the challenges faced by patients and their families, Dr. De Matteis was instrumental in establishing the Italian Patient Association for Lowe Syndrome. This organization plays a crucial role in providing support and resources to families, raising public awareness, and fostering research initiatives. Under her guidance, the association has become a beacon of hope for many, advocating for patient rights and accessibility to treatments.

The Innovation in Her Research

One of the most significant aspects of Dr. De Matteis' research is her innovative approach to finding treatments. By understanding the specific molecular mechanisms that fail in Lowe Syndrome, she aims to identify potential drugs that can rectify these cellular dysfunctions. This approach is at the forefront of personalized medicine, where treatments are tailored to the unique genetic and molecular characteristics of a patient's condition.

Her work involves detailed analysis of the PI(4,5)P2 enzyme, which is crucial in cellular functions and is impaired in Lowe Syndrome patients. By focusing on restoring the normal function of this enzyme, her research opens up possibilities for developing drugs that could potentially reverse or mitigate the debilitating effects of the disease.

The Importance of Research on Rare Diseases

Dr. De Matteis' contributions extend beyond the realm of Lowe Syndrome. Her work underscores the importance of understanding rare diseases, which often lack sufficient research funding and public attention. By elucidating the molecular mechanisms underlying these conditions, researchers can pave the way for innovative treatments that can significantly improve the quality of life for patients.

Furthermore, her research highlights the critical role of patient associations in bridging the gap between medical research and patient needs. These organizations are vital in advocating for research funding, supporting families, and connecting researchers with communities.


Dr. Antonella De Matteis’ presentation at the Galileo Festival was not just a dissemination of her findings but a call to action for increased attention and resources towards rare diseases like Lowe Syndrome. Her transition from clinical practice to research and her innovative approach in targeting cellular mechanisms for drug development exemplify the evolving landscape of medical research. Through her efforts, there is renewed hope for many families, and a clearer path forward in the fight against rare genetic disorders.

watch the video here: